Bluejay Diagnostics Inc (NASDAQ:BJDX) currently has a daily average trading volume of 1.43M but it saw 1254826 shares traded in last market. With a market cap of 1.59M USD, the company’s current market price of $0.26 came falling about -10.82 while comparing to the previous closing price of $0.29. In past 52 weeks, the stock remained buoying in the range of price level as high as $65.60 and as low as $0.25. In the recent trading on the day, stock has struck highest price mark of $0.255 while lowest mark touched by it was $0.295.
Taking a look at 20-day trading activity of Bluejay Diagnostics Inc (BJDX) gives us an average price of $0.4120, while its current price level is -99.61% below from 52-week high level whereas it is 1.82% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.1073 while that of 200 days or SMA-200 reads an average of $8.2869. A closer look into the stock’s movement over the week reveals that its volatility is standing at 18.10% during that period while stretching the period over a month that increases to 21.01%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 26.84 which implies that the stock is in oversold territory.
Over the week, BJDX’s stock price is moving -14.36% down while it is -57.31% when we observe its performance for the past one month. Year-to-date it is -97.39% down and over the past year, the stock is showing a downside performance of -99.56%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -19.2 beaten by the consensus estimate of -9.6 for the same. The company is expected to be releasing its next quarterly report on 2024-Mar-28, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Bluejay Diagnostics Inc’s total number of outstanding shares is 6.25M with 3.03% of that held by the insiders while 2.71% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -106.84% and return on equity (ROE) at -125.25%. Stock’s beta reads 0.79. Stock has a price to book (P/B) ratio of 0.08. Its return on asset (ROA) is -97.27% on average.
